JWN vs. MED

Last updated Apr 1, 2026

Compare and contrast key facts about Nordstrom, Inc. (JWN) and Medifast, Inc. (MED).

Performance

JWN vs. MED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nordstrom, Inc. (JWN) and Medifast, Inc. (MED). The values are adjusted to include any dividend payments, if applicable.

JWN vs. MED - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
JWN Nordstrom, Inc.	0.00%	4.23%	35.73%	19.92%	-26.18%	-27.52%	-22.76%	-8.38%	1.14%	2.30%
MED Medifast, Inc.	-4.59%	-39.39%	-73.79%	-38.34%	-42.31%	9.36%	86.18%	-9.73%	82.11%	72.33%

Fundamentals

Total Revenue (TTM) JWN : $15.02B MED : $385.79M
Gross Profit (TTM) JWN : $5.62B MED : $275.19M
EBITDA (TTM) JWN : $1.31B MED : $1.45M

Returns By Period

JWN

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

MED

• 1D: 2.00%
• 1M: -3.23%
• YTD: -4.59%
• 6M: -25.46%
• 1Y: -24.41%
• 3Y*: -53.24%
• 5Y*: -44.69%
• 10Y*: -7.88%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

JWN vs. MED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MED

MED Risk / Return Rank: 16
MED Sharpe Ratio Rank: 14
MED Sortino Ratio Rank: 15
MED Omega Ratio Rank: 17
MED Calmar Ratio Rank: 18
MED Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JWN vs. MED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nordstrom, Inc. (JWN) and Medifast, Inc. (MED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	JWN	MED	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.64	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-1.00	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.17	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.03	—

Correlation

The correlation between JWN and MED is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

JWN vs. MED - Dividend Comparison

JWN's dividend yield for the trailing twelve months is around 1.01%, while MED has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JWN Nordstrom, Inc.	1.01%	2.03%	3.15%	4.12%	4.71%	0.00%	1.19%	3.62%	3.18%	3.12%	3.09%	12.71%
MED Medifast, Inc.	0.00%	0.00%	0.00%	7.36%	5.69%	2.71%	2.30%	3.08%	1.75%	2.06%	2.57%	0.82%

Drawdowns

Drawdown Indicators

	JWN	MED	Difference
Max Drawdown Largest peak-to-trough decline	—	-98.40%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-37.39%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-96.76%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-96.76%	—
Current Drawdown Current decline from peak	—	-96.54%	—
Average Drawdown Average peak-to-trough decline	—	-50.56%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	19.18%	—

Volatility

Volatility by Period

	JWN	MED	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	12.03%	—
Volatility (6M) Calculated over the trailing 6-month period	—	24.44%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	38.63%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	44.85%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	47.09%	—

Financials